Publication Date
In 2025 | 11 |
Since 2024 | 29 |
Since 2021 (last 5 years) | 56 |
Since 2016 (last 10 years) | 118 |
Since 2006 (last 20 years) | 541 |
Descriptor
Drug Therapy | 651 |
Symptoms (Individual… | 651 |
Children | 210 |
Outcomes of Treatment | 196 |
Adolescents | 161 |
Attention Deficit… | 157 |
Depression (Psychology) | 127 |
Intervention | 114 |
Attention Deficit Disorders | 110 |
Clinical Diagnosis | 106 |
Hyperactivity | 103 |
More ▼ |
Source
Author
Publication Type
Education Level
Audience
Practitioners | 18 |
Teachers | 14 |
Parents | 11 |
Counselors | 6 |
Support Staff | 6 |
Administrators | 4 |
Students | 4 |
Community | 2 |
Researchers | 1 |
Location
United Kingdom | 11 |
Canada | 10 |
Australia | 9 |
United States | 9 |
Netherlands | 6 |
Sweden | 6 |
Germany | 3 |
Michigan | 3 |
Utah | 3 |
Brazil | 2 |
China | 2 |
More ▼ |
Laws, Policies, & Programs
Rehabilitation Act 1973… | 6 |
Individuals with Disabilities… | 5 |
Americans with Disabilities… | 1 |
Education for All Handicapped… | 1 |
Individuals with Disabilities… | 1 |
Vocational Rehabilitation Act… | 1 |
Assessments and Surveys
What Works Clearinghouse Rating
Jessica E. Rast; Sha Tao; Whitney Schott; Lindsay L. Shea; Edward S. Brodkin; Connor M. Kerns; Charles E. Leonard; Michael J. Murray; Brian K. Lee – Journal of Autism and Developmental Disorders, 2025
Children with autism frequently present with complex mental health diagnoses and psychotropic medications are often a component of comprehensive biopsychosocial treatment plans for these conditions. The purpose of this study is to provide rates and patterns of psychotropic medication use, and predictors thereof, in children and youth with autism…
Descriptors: Children, Autism Spectrum Disorders, Drug Therapy, Adolescents
Kazunari Yoshida; Yona Lunsky; Daniel J. Müller; Pushpal Desarkar – Journal of Autism and Developmental Disorders, 2025
The aim of this study was to compare the rates of psychotropic medication use and psychotropic polypharmacy between autistic adults with and without intellectual disability (ID) and to examine factors associated with psychotropic medication use and psychotropic polypharmacy in autistic adults, stratified by the presence of ID. We conducted a…
Descriptors: Drug Therapy, Adults, Autism Spectrum Disorders, Intellectual Disability
Riley A. Argonis; Ernest V. Pedapati; Kelli C. Dominick; Katherine Harris; Martine Lamy; Cara Fosdick; Lauren Schmitt; Rebecca C. Shaffer; Elizabeth Smith; Meredith Will; Christopher J. McDougle; Craig A. Erickson – Journal of Autism and Developmental Disorders, 2025
Introduction: Depression impacts many individuals with autism spectrum disorder (ASD), carrying increased risk of functional impairment, hospitalization, and suicide. Prescribing medication to target depression in patients with ASD occurs despite limited available systematic data describing medication management of depression in this population.…
Descriptors: Drug Therapy, Depression (Psychology), Autism Spectrum Disorders, Patients
Ulrich Elbing; Sebastian Appelbaum; Thomas Ostermann – Journal of Intellectual Disabilities, 2024
This study aims to contribute to the knowledge about lacking or contradictory effects of benzodiazepine on hyperaroused or aggressive behaviour in persons with intellectual disability (ID). We conducted a retrospective and natural case study in a person with mild ID and multiple adverse childhood experiences (ACE), using routine diary data…
Descriptors: Mild Intellectual Disability, Drug Therapy, Behavior Problems, Symptoms (Individual Disorders)
Roselyne Bulonza; Kim Watkins; Richard Parsons; Bruce Sunderland; Andrew Whitehouse; Rima Caccetta – Autism: The International Journal of Research and Practice, 2024
There is a significant variability in the prevalence of psychotropic medication use among young autistic persons worldwide and this is under-studied in Australia. Apart from risperidone, approved by the Therapeutic Goods Administration to manage challenging behaviour, the appropriateness of other psychotropic medications prescribed to young…
Descriptors: Foreign Countries, Autism Spectrum Disorders, Multiple Disabilities, Children
Silverberg, Benjamin; Sharon, Melinda J.; Makati, Devan; Mott, Mariah; Rose, William D. – Journal of American College Health, 2023
Background: Familiarity breeds complacency. One case of sore throat can start to sound like another. However, even common viral and bacterial infections can lead to serious sequelae. Clinicians cannot make a diagnosis if they do not consider it in their differential. Case: The presentation -- and subsequent hospitalization -- of a septic 19…
Descriptors: College Students, Symptoms (Individual Disorders), Microbiology, Communicable Diseases
Miguel Morales-Navas; Cristian Perez-Fernandez; Sergio Castaño-Castaño; Ainhoa Sánchez-Gil; María Teresa Colomina; Xavier Leinekugel; Fernando Sánchez-Santed – Journal of Autism and Developmental Disorders, 2025
In recent years, exposures to organophosphate pesticide have been highlighted as a possible cause or aggravating factor of autism spectrum disorder (ASD). The present study examined if Wistar rats prenatally exposed to chlorpyrifos (CPF) at a dose of 1 mg/kg in GD 12.5-15.5 could express similar behaviors to those exposed to valproic acid (VPA,…
Descriptors: Autism Spectrum Disorders, Hazardous Materials, Animals, Research
Maeve Goodall; Kate Irving; Mary Nevin – Journal of Applied Research in Intellectual Disabilities, 2024
Background: Pain recognition and assessment in individuals with profound intellectual disabilities are challenging. Exploring effective methods of addressing this is essential. This study aims to discover current nursing practice in this area of care as the first of a four-phased appreciative inquiry study, to inform further research and practice.…
Descriptors: Pain, Severe Intellectual Disability, Nurses, Role
Craig B. H. Surman; Daniel M. Walsh; Joseph B. Bond – Journal of Attention Disorders, 2024
Objective: We appraised whether FDA registration trials for ADHD pharmacotherapy in adults provides comparable information to inform treatment expectations. Method: Comparison of ADHD outcome measure patterns in ADHD pharmacotherapy FDA drug label source studies. Results: Among stimulants, from fixed-dose titration data, amphetamine agents had…
Descriptors: Drug Therapy, Attention Deficit Hyperactivity Disorder, Adults, Stimulants
Fethiye Kiliçaslan; Aybike Tan; Zulkif Tanriverdi – Journal of Attention Disorders, 2025
Introduction: Conflicting findings exist regarding the link between attention deficit hyperactivity disorder (ADHD) and cardiovascular diseases. This study aimed to evaluate the frontal QRS-T (fQRS-T) angle and its correlation with symptom severity in children diagnosed with ADHD. Methods: The study population consisted of 172 patients diagnosed…
Descriptors: Children, Attention Deficit Hyperactivity Disorder, Control Groups, Brain Hemisphere Functions
Trine Lise Bakken; Jane Margrete Askeland Hellerud; Arvid Nikolai Kildahl; Ann Magritt Solheim-Inderberg; Oddbjørn Hove; Sissel Berge Helverschou – Journal of Autism and Developmental Disorders, 2025
Autistic people with intellectual disabilities appear to be at increased risk of schizophrenia. While current recommendations emphasize adapting interventions used for people with schizophrenia in general, few studies to date have investigated treatment of co-occurring schizophrenia in this specific population. To explore what interventions are…
Descriptors: Autism Spectrum Disorders, Intellectual Disability, Schizophrenia, Comorbidity
Zarif Cagla Arslan; Sabah Tuzun; Can Öner; Nazli Haciagaoglu; Hüseyin Çetin; Engin Ersin Simsek – Health Education Research, 2024
Although various approaches have been used in diabetes self-management education (DSME) programs, the effect of DSME programs on glycemic control is controversial. This study aimed to compare the effects of structured individual education and combined education on glycemic regulation in type 2 diabetes mellitus (T2DM). This study included T2DM…
Descriptors: Diabetes, Patient Education, Biochemistry, Hospitals
Natalia Van Doren; Robert W. Roeser – ECNU Review of Education, 2025
Purpose: School teachers show higher levels of internalized distress compared to those in many other professions. In two exploratory studies, we examine the relative and interactive impacts of mindfulness training (MT) and medication use on reductions in depressive and anxious symptoms in teachers over time. Design/Approach/Methods: These…
Descriptors: Metacognition, Drug Therapy, Depression (Psychology), Anxiety
Peter Jacobsson; Tove Granqvist; Christopher J. Hopwood; Robert F. Krueger; Bo Söderpalm; Thomas Nilsson – Journal of Attention Disorders, 2025
Objectives: Non-adherence to medication is common in the adult ADHD clinical group. The goal of this pre-registered study was to examine whether the DSM-5 Alternative Model of Personality Disorder (AMPD), generality personality dysfunction (LPFS-BF 2.0) or maladaptive personality traits (PID-5), can predict time to premature discontinuation of…
Descriptors: Personality Traits, Predictor Variables, Drug Therapy, Attention Deficit Hyperactivity Disorder
MacDonell, Karen Kolmodin; Dailey, Rhonda; Gibson-Scipio, Wanda; Wang, Bo; Dinaj-Koci, Veronica; Bruzzese, Jean-Marie – Health Education & Behavior, 2023
African American emerging adults (age 18-29 years) tend to have poor asthma outcomes, possibly due to poor adherence to medication. Few studies have explored barriers to controller adherence in this population. This study utilized electronic daily diaries to assess barriers to adherence and asthma symptoms among 141 African American emerging…
Descriptors: Barriers, Drug Therapy, Compliance (Psychology), African Americans